Literature DB >> 15863545

Nuchal translucency thickness in fetuses with chromosomal translocation at 11-12 weeks of gestation.

Po-Jen Cheng1, Shuenn-Dhy Chang, Sheng-Wen Shaw, Yung-Kuei Soong.   

Abstract

OBJECTIVE: To investigate differences in nuchal translucency thickness among fetuses in which either parent is a balanced chromosome translocation carrier.
METHODS: A prospective observational study was conducted with 98 pregnant women in the first trimester. Each had been advised to undergo chorionic villous sampling for fetal karyotyping for the indication of parental balanced chromosomal translocation. Fetal nuchal translucency measurement was performed before chorionic villous sampling. Nuchal translucency thickness was compared among fetuses with 3 kinds of karyotypes: normal, balanced translocation, and unbalanced translocation.
RESULTS: There were no differences in maternal age, gestational age, parity, and number of previous miscarriages among pregnancies with normal karyotype, balanced chromosomal translocation, and unbalanced chromosomal translocation. A significantly greater nuchal translucency thickness was shown in the unbalanced chromosomal translocation group (2.9 +/- 1.2 mm) compared with both the balanced chromosomal translocation group (1.0 +/- 0.6 mm; P < .001) and the normal karyotype group (1.0 +/- 0.8 mm; P < .001). No statistically significant difference in nuchal translucency thickness was found between the balanced chromosomal translocation group and normal karyotype group (P = .991). Nuchal translucency thickness did not differ significantly between unbalanced chromosomal translocation dependent on paternal origin and that dependent on maternal origin (P = .611).
CONCLUSION: In fetuses with unbalanced chromosomal translocation, nuchal translucency thickness tends to be greater, and thus nuchal translucency measurement might be considered part of the investigation for pregnancies marked by a parental balanced chromosomal translocation.

Entities:  

Mesh:

Year:  2005        PMID: 15863545     DOI: 10.1097/01.AOG.0000158862.84467.d7

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  First-trimester combined screening is effective for the detection of unbalanced chromosomal translocations at 11 to 12 weeks of gestation.

Authors:  Shangyu Huang; Chialin Chang; Pojen Cheng; Chinghua Hsiao; Yungkuei Soong; Tao Duan
Journal:  Reprod Sci       Date:  2013-10-31       Impact factor: 3.060

2.  Neonatal periventricular leukomalacia without evidence of twin-to-twin transfusion syndrome following discordance in nuchal translucency: a case report.

Authors:  Yoshiyuki Nakajima; Naoki Masaoka
Journal:  J Med Ultrason (2001)       Date:  2012-03-08       Impact factor: 1.314

3.  The utility of nuchal translucency ultrasound in identifying rare chromosomal abnormalities not detectable by cell-free DNA screening.

Authors:  Victoria K Berger; Mary E Norton; Teresa N Sparks; Monica Flessel; Rebecca J Baer; Robert J Currier
Journal:  Prenat Diagn       Date:  2019-12-02       Impact factor: 3.050

4.  Cystic Dilation of the Aqueductus Sylvii in Case of Trisomy 17p11.2-pter with the Deletion of the Terminal Portion of the Chromosome 6.

Authors:  Emese Horváth; János Sikovanyecz; Attila Pál; László Kaiser; Bálint L Bálint; Póliska Szilárd; Zoltán Kozinszky; János Szabó
Journal:  Case Rep Med       Date:  2011-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.